Pregnancy Anemia Clinical Trial
Official title:
Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
Erythroferrone (ERFE) is a recently identified iron-regulatory hormone that couples iron homeostasis to erythropoiesis but at this time there are no human data on this hormone in pregnant women and their neonates. The investigators hypothesize that ERFE is a sensitive biomarker of iron deficiency and anemia in pregnancy and neonates, and that it mediates the feedback mechanism to correct iron deficiency and anemia. To address this research gap, the investigators will measure ERFE in maternal serum, umbilical cord serum and placental tissue using an existing biospecimen archive.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03522428 -
Vitamin B12 Pregnancy Supplementation
|
Phase 4 | |
| Not yet recruiting |
NCT06061393 -
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
|
Phase 4 | |
| Recruiting |
NCT05975125 -
The Effect of Vitamin C for Iron Supplementation During Pregnancy With Risk of Anemia
|
N/A | |
| Active, not recruiting |
NCT05739097 -
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
|
||
| Recruiting |
NCT03448432 -
Prevalence Study of the Etiology of Pregnancy Anemia
|
N/A | |
| Enrolling by invitation |
NCT04810546 -
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
|
N/A | |
| Withdrawn |
NCT03873571 -
Adherence of Iron Succinylate Therapy in Pregnancy
|
||
| Completed |
NCT04812821 -
Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
|